David Pesántez, Medical Director, Clinical Development, Oncology at Pathos AI, shared on LinkedIn:
“I’m happy to share that I’m starting a new position as Medical Director, Clinical Development, Oncology at Pathos AI, joining the team at its New York office!
Pathos is redefining drug development through AI and multimodal data, accelerating the development of breakthrough therapies and paving the way for a new standard in oncology drug development.
Proud to be part of this journey.
Exciting times ahead!”
This can be interesting:
Miguel Bronchud: AI Can Guide Cancer Drug Discovery, but Clinical Validation Still Matters
